Ajinomoto to buy Forge Biologics for $620 million

Ajinomoto has agreed to purchase Forge Biologics, a viral vector and plasmid contract development and manufacturing organization, for $620 million. “Forge brings to Ajinomoto an entirely new capability that will vitally enhance our Bio-Pharma Services business,” Yasuyuki Otake, general manager of Ajinomoto’s biopharmaceutical services business, says in a statement. Forge has a 18,580 m2 facility in Columbus, Ohio, called the Hearth. Forge, with approximately 300 employees, will operate as a subsidiary of Ajinomoto.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts